119 related articles for article (PubMed ID: 24950910)
1. Pentraxin 3: a novel biomarker for predicting progression from prostatic inflammation to prostate cancer.
Stallone G; Cormio L; Netti GS; Infante B; Selvaggio O; Fino GD; Ranieri E; Bruno F; Prattichizzo C; Sanguedolce F; Tortorella S; Bufo P; Grandaliano G; Carrieri G
Cancer Res; 2014 Aug; 74(16):4230-8. PubMed ID: 24950910
[TBL] [Abstract][Full Text] [Related]
2. Serum pentraxin 3 levels in term neonates with persistent pulmonary hypertension.
Asal AEA; Oshaiba ZF; Mansour ENA; Abd Elaziz OH; Nasr AAA
J Neonatal Perinatal Med; 2024; 17(1):7-11. PubMed ID: 38393925
[TBL] [Abstract][Full Text] [Related]
3. Post-COVID Trajectory of Pentraxin 3 Plasma Levels Over 6 Months and Their Association with the Risk of Developing Post-Acute Depression and Anxiety.
De Lorenzo R; Mazza MG; Sciorati C; Leone R; Scavello F; Palladini M; Merolla A; Ciceri F; Bottazzi B; Garlanda C; Benedetti F; Rovere-Querini P; Manfredi AA
CNS Drugs; 2024 Jun; 38(6):459-472. PubMed ID: 38658499
[TBL] [Abstract][Full Text] [Related]
4. Plasma Levels of Pentraxin 3: A Potential Prognostic Biomarker in Urinary Bladder Cancer Patients.
Vikerfors A; Davidsson S; Carlsson J; Jerlström T
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542446
[TBL] [Abstract][Full Text] [Related]
5. The pentraxin family in autoimmune disease.
Li Y; Zhang S; Liu J; Zhang Y; Zhang N; Cheng Q; Zhang H; Wu X
Clin Chim Acta; 2023 Nov; 551():117592. PubMed ID: 37832905
[TBL] [Abstract][Full Text] [Related]
6. Animal protein intake is directly associated with serum level of pentraxin 3 in hemodialysis patients.
Navab F; Foshati S; Bagherniya M; Askari G; Moeinzadeh F; Gholaminejad A; Clark CCT; Rouhani MH
Sci Rep; 2023 Dec; 13(1):21600. PubMed ID: 38062075
[TBL] [Abstract][Full Text] [Related]
7. Pentraxin 3: A promising therapeutic target for cardiovascular diseases.
Ye X; Wang Z; Lei W; Shen M; Tang J; Xu X; Yang Y; Zhang H
Ageing Res Rev; 2024 Jan; 93():102163. PubMed ID: 38092307
[TBL] [Abstract][Full Text] [Related]
8. Pentraxin 3 in Myocarditis: Proof-of-Principle Assessment as a Diagnostic and Prognostic Biomarker.
Villatore A; Monno A; Sciorati C; Rovere-Querini P; Sala S; Carino D; De Bonis M; Cianflone D; Manfredi AA; Peretto G
J Cardiovasc Transl Res; 2024 Mar; ():. PubMed ID: 38546963
[TBL] [Abstract][Full Text] [Related]
9. Serum Pentraxin 3 as Promising Biomarker for the Long-Lasting Inflammatory Response of COVID-19.
Capra AP; Crupi L; Pantò G; Repici A; Calapai F; Squeri R; Ardizzone A; Esposito E
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762499
[TBL] [Abstract][Full Text] [Related]
10. miRNA-21 Serum Evaluation in BPH, Hormone Sensitive Prostate Cancer, and Castrate Resistant Prostate Cancer: Attempt for Diagnostic Biomarker Evaluation.
Seputra KP; Purnomo BB; Susianti H; Kalim H; Purnomo AF
Acta Inform Med; 2021 Dec; 29(4):266-269. PubMed ID: 35197661
[TBL] [Abstract][Full Text] [Related]
11. Pentraxin 3: A Main Driver of Inflammation and Immune System Dysfunction in the Tumor Microenvironment of Glioblastoma.
Scuderi SA; Ardizzone A; Salako AE; Pantò G; De Luca F; Esposito E; Capra AP
Cancers (Basel); 2024 Apr; 16(9):. PubMed ID: 38730589
[TBL] [Abstract][Full Text] [Related]
12. Nutraceuticals in Prostate Disease: The Urologist's Role.
Curtis Nickel J; Shoskes D; Roehrborn CG; Moyad M
Rev Urol; 2008; 10(3):192-206. PubMed ID: 18836556
[TBL] [Abstract][Full Text] [Related]
13. The Role of Pentraxin 3 in Gastrointestinal Cancers.
Zajkowska M; Mroczko B
Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136377
[TBL] [Abstract][Full Text] [Related]
14. Pentraxin 3: A Biomarker Link between Inflammation and Cardiovascular Risk among Obese Children.
Chen YT; Wang HH; Liu PY
Acta Cardiol Sin; 2021 Mar; 37(2):184-185. PubMed ID: 33716460
[No Abstract] [Full Text] [Related]
15. Inflammation in prostate cancer progression and therapeutic targeting.
Stark T; Livas L; Kyprianou N
Transl Androl Urol; 2015 Aug; 4(4):455-63. PubMed ID: 26816843
[TBL] [Abstract][Full Text] [Related]
16. Immune Infiltration and Prostate Cancer.
Strasner A; Karin M
Front Oncol; 2015; 5():128. PubMed ID: 26217583
[TBL] [Abstract][Full Text] [Related]
17. Inflammation and prostate cancer: friends or foe?
Taverna G; Pedretti E; Di Caro G; Borroni EM; Marchesi F; Grizzi F
Inflamm Res; 2015 May; 64(5):275-86. PubMed ID: 25788425
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of the inflammatory factor pentraxin-3 suppresses growth and invasion of lung adenocarcinoma through the AKT and NF-kappa B pathways.
Hu FQ; Qiao T; Xie X; Hu R; Xiao HB
J Biol Regul Homeost Agents; 2014; 28(4):649-57. PubMed ID: 25620175
[TBL] [Abstract][Full Text] [Related]
19. Pentraxin-3 Silencing Suppresses Gastric Cancer-related Inflammation by Inhibiting Chemotactic Migration of Macrophages.
Choi B; Lee EJ; Park YS; Kim SM; Kim EY; Song Y; Kang SW; Rhu MH; Chang EJ
Anticancer Res; 2015 May; 35(5):2663-8. PubMed ID: 25964543
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of Pentraxin 3 suppresses tumorigenicity and metastasis of human cervical cancer cells.
Ying TH; Lee CH; Chiou HL; Yang SF; Lin CL; Hung CH; Tsai JP; Hsieh YH
Sci Rep; 2016 Jul; 6():29385. PubMed ID: 27377307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
